Iodinated contrast media are essential for diagnostic and interventional radiological and cardiological procedures, but may cause kidney damage. Intravenous hydration is the current cornerstone for prevention of contrast-induced acute kidney injury; however, new data from the AMACING trial suggest that this approach might not be beneficial in low-risk patients.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Windecker, S. et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 35, 2541–2619 (2014).
Lameire, N., Kellum, J. A. & KDIGO AKI Guideline Work Group. Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (part 2). Crit. Care 17, 205 (2013).
Nijssen, E. C. et al. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet http://dx.doi.org/10.1016/S0140-6736(17)30057-0 (2017).
Liu, Y. et al. Excessively high hydration volume may not be associated with decreased risk of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with renal insufficiency. J. Am. Heart Assoc. 5, e003171 (2016).
McDonald, R. J. et al. Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality. Radiology 273, 714–725 (2014).
Gurm, H. S. et al. Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J. Am. Coll. Cardiol. 58, 907–914 (2011).
Briguori, C. et al. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury. Circulation 124, 1260–1269 (2011).
Brar, S. S. et al. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial. Lancet 383, 1814–1823 (2014).
Mehran, R. et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J. Am. Coll. Cardiol. 44, 1393–1399 (2004).
Gurm, H. S., Seth, M., Kooiman, J. & Share, D. A novel tool for reliable and accurate prediction of renal complications in patients undergoing percutaneous coronary intervention. J. Am. Coll. Cardiol. 61, 2242–2248 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Briguori, C., Signoriello, G. Intravenous hydration for the prevention of CIAKI. Nat Rev Nephrol 13, 264–266 (2017). https://doi.org/10.1038/nrneph.2017.41
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2017.41
This article is cited by
-
Random forest for prediction of contrast-induced nephropathy following coronary angiography
The International Journal of Cardiovascular Imaging (2020)